Product Information
DULOXETINE HCL DR 40 MG CAP is a generic product labeled by Ajanta Pharma USA Inc., priced at $1.3767 per EA under NDC 27241016430. Its NADAC has been published 378 times since May 29, 2019.
FDA first approved this application on Jan 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241016430
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208706FDA Approved
1/6/2017
TE Code
AB
On Market Since
3/25/2019
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 40 MG CAP has been published 378 times since May 29, 2019, and over the history we have for it it has declined 54.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3767 per EA |
|---|---|
| All-time high | $3.1127 (Oct 16, 2019) |
| All-time low | $0.9547 (Jul 17, 2024) |
| 52-week high | $1.4045 |
| 52-week low | $1.0466 |
| Median price | $1.7176 |
| Average price | $1.7851 |
| Largest weekly change | +46.1% (Aug 21, 2024) |
| Weeks tracked | 378 |
| Tracking since | May 29, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 40 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 40 MG CAP, manufactured by Ajanta Pharma USA Inc., is $1.3767 per EA (NDC 27241016430), effective Aug 19, 2026.
How has the price of DULOXETINE HCL DR 40 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 40 MG CAP has declined 54.9%. It has been tracked across 378 weekly CMS publications since May 29, 2019.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 40 MG CAP?
Since May 29, 2019, the NADAC for DULOXETINE HCL DR 40 MG CAP has ranged from a low of $0.9547 (Jul 17, 2024) to a high of $3.1127 (Oct 16, 2019), with a median of $1.7176 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 40 MG CAP?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DULOXETINE HCL DR 40 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DULOXETINE HCL DR 40 MG CAP?
DULOXETINE HCL DR 40 MG CAP (NDC 27241016430) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.